1.51907

LiChrospher^® 100 RP-18 endcapped (5 µm) HPLC Columns

L x I.D. 125 mm x 2 mm Hibar^® RT HPLC Column

• Sinónimos: TM=["LiChrospher"] C18 HPLC column
• Código UNSPSC: 41115700
• NACRES: SB.52
• columna L × D.I.: 12.5 cm × 2 mm
• superficie: 350 m²/g
• tamaño de partícula: 5 μm
• grupo activo de la matriz: C18 bonding phase
• tamaño de poro: 100 Å pore size
• Matriz: fully porous particle

Propiedades

• Nombre del producto: LiChrospher^® 100 RP-18 endcapped (5µm) Hibar^® RT 125-2, suitable for HPLC
• Materiales: stainless steel column
• Nivel de calidad: 100
• Agency: suitable for USP L1
• Línea del producto: LiChrospher^®
• Características: endcapped
• envase: 1 ea of
• Extensión del etiquetado: 21.6% Carbon loading
• Parámetros: 400 bar pressure; 60 °C max. temp.
• técnicas: HPLC: suitable; mass spectrometry (MS): suitable (Low - Medium)
• columna L × D.I.: 12.5 cm × 2 mm
• superficie: 350 m²/g
• Matriz: fully porous particle
• grupo activo de la matriz: C18 bonding phase
• tamaño de partícula: 5 μm
• tamaño de poro: 100 Å pore size
• Intervalo de pH operativo: 2-7.5
• técnica de separación: reversed phase; supercritical fluid (SFC)
• temp. de almacenamiento: no temp limit

Descripción

Descripción general

HPLC column

Aplicación

• Liquid chromatographic determination of lumacaftor in the presence of ivacaftor and identification of five novel degradation products using high-performance liquid chromatography ion trap time-of-flight mass spectrometry: This study effectively utilizes the Ascentis^® Express F5, 2.7 μm HPLC column to analyze complex pharmaceutical mixtures and identify degradation products, demonstrating the column′s high-resolution capabilities and robust performance in pharmaceutical analysis (Özcan et al., 2023).


• Stability-indicating LC-MS/MS and LC-DAD methods for robust determination of tasimelteon and high resolution mass spectrometric identification of a novel degradation product: This research highlights the use of the Ascentis^® Express F5 HPLC column in developing stability-indicating methods for the analysis of tasimelteon, underscoring its crucial role in ensuring the quality and safety of pharmaceuticals through advanced analytical techniques (Özcan et al., 2020).

Información legal

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

Hibar is a registered trademark of Merck KGaA, Darmstadt, Germany

LiChrospher is a registered trademark of Merck KGaA, Darmstadt, Germany